hidroxicloroquina na hemossiderose pulmonar idiopática: caso clínico hydroxychloroquine in pediatric idiopathic pulmonary hemosiderosis: a case report

Clicks: 242
ID: 238443
2006
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #52 of 210 articles by views in the journal of applied psychology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 210 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Os autores apresentam o caso de uma criança com hemossiderose pulmonar idiopática grave, que, após ter iniciado tratamento com hidroxicloroquina, apresentou alteração do seu curso clínico, com melhoria significativa e duradoura. A eficácia desta terapêutica é salientada. Reportam ainda a ocorrência de exacerbação clínica, com hemoptise, após administração de vacina antigripal.
The authors present the case of a child with severe idiopathic pulmonary hemosiderosis who after having begun treatment with hydroxychloroquine had a significant and lasting improvement. The efficacy of this therapeutic is pointed out. They also report the occurrence of clinical exacerbation, with hemoptysis, after receiving an influenza vaccine.
Reference Key
almeida2006revistahidroxicloroquina Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Marta Pinto de Almeida;Guilhermina Reis;Margarida Guedes
Journal the journal of applied psychology
Year 2006
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.